Identifying Men Who Can Remain on Active Surveillance Despite Biopsy Reclassification to Grade Group 2 Prostate Cancer.
J Urol
; 210(1): 99-107, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37042826
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Prostate-Specific Antigen
Type of study:
Prognostic_studies
/
Screening_studies
Limits:
Humans
/
Male
Language:
En
Journal:
J Urol
Year:
2023
Document type:
Article